Thrombosis: A major contributor to global disease burden

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 34, Issue 11, 2014, Pages 2363-2371

  Raskob, G E ^a   Angchaisuksiri, P ^b   Blanco, A N ^c   Buller, H ^d   Gallus, A ^e   Hunt, B J ^f   Hylek, E M ^g   Kakkar, A ^h   Konstantinides, S V ⁱ   McCumber, M ^a   Ozaki, Y ^j   Wendelboe, A ^a   Weitz, J I ^k  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e FLINDERS MEDICAL CENTRE   (Australia)

^f GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

ⁱ UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^j UNIVERSITY OF YAMANASHI   (Japan)

^k MCMASTER UNIVERSITY   (Canada)

more..

Author keywords

Pulmonary embolism; Thrombosis; Venous thromboembolism; Venous thrombosis

Indexed keywords

BRAIN ISCHEMIA; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CATHETER INFECTION; CEREBROVASCULAR ACCIDENT; DISABILITY; GENERAL ASPECTS OF DISEASE; GLOBAL DISEASE BURDEN; HEALTH CARE POLICY; HOSPITAL ACQUIRED PNEUMONIA; HOSPITALIZATION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; PREVALENCE; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH SERVICE; RESOURCE ALLOCATION; REVIEW; RISK FACTOR; SOCIOECONOMICS; SYSTEMATIC REVIEW; VENOUS THROMBOEMBOLISM; AGE; ANCESTRY GROUP; COMPARATIVE STUDY; COST OF ILLNESS; HEALTH; MORTALITY; SOCIAL CLASS; STATISTICS AND NUMERICAL DATA; VENOUS THROMBOSIS;

AGE FACTORS; CONTINENTAL POPULATION GROUPS; COST OF ILLNESS; GLOBAL HEALTH; HUMANS; INCIDENCE; SOCIAL CLASS; VENOUS THROMBOSIS;

EID: 84911906787     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1111/jth.12698     Document Type: Review

References (93)

1. Hunter DJ, Fineberg HV. Convergence to common purpose in global health. N Engl J Med. 2014;370:1753-1755.
2. Jamison DT, Summers LH, Alleyne G, et al. Global health 2035: a world converging within a generation. Lancet 2013;382:1898-1955.
3. Lozano R, Nag havi M, Foreman K, Benjamin EJ, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-2128.
4. Horton R. GBD 2010: understanding disease, injury, and risk. Lancet 2012;380:2053-2054.
5. Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, Nag havi M, Salomon JA, Shibuya K, Vos T, Wikler D, Lopez AD. GBD 2010: design, definitions, and metrics. Lancet 2012;380:2063-2066.
6. Murray CJ, Vos T, Lozano R, et al. Disabil ity-adjusted life years (DALYs) for 291 diseases and 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2197-2223.
7. Feigin V, Forouzanfar M, Krishnamurthi R, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2014;383: 245-255.
8. Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M; VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007;98:756-764.
9. Yusuf HR,Tsai J,Atrash HK,Boulet S,Grosse SD. Venous thromboembolism in adult hospitalizations?United States 2007- 2009. MMWR Morb Mortal Wkly Rep 2012;61:401-404.
10. Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, Cook DJ, Balekian AA, Klein RC, Le H, Schulman S, Murad MH; American College of Chest Physicians. Prevention of VTE in nonsurgical patients: Antithrom botic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e195S-e226S.
11. Gould MK, Garcia DA, Wren SM, Kara nicolas PJ, Arcelus JI, Heit JA, Samama CM; American College of Chest Physicians. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evid ence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e227S-e277S.
12. Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW Jr; American College of Chest Physicians. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e278S-e325S.
13. Nicolaides AN, Fareed J, Kakkar AK, et al. Prevention and treatment of venous thromboembolism-International Consensus Statement. Int Angiol. 2013;32:111-260.
14. Hald EM, Enga KF, Lø chen ML, Mathiesen EB, Njølstad I, Wilsgaard T, Braekkan SK, Hansen JB. Venous thromboembolism increases the risk of atrial fibrillation: the Tromso study. J Am Heart Assoc. 2014;3:e000483.
15. Holst AG, Jensen G, Prescott E. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation. 2010;121:1896 -1903.
16. Moretti AM, Tafuri S, Parisi D, Germinario C. Epidemiology of pulmonary embolism in Apulia from analysis of current data. Monaldi Arch Chest.Dis. 2010;73:18-24.
17. Severi nsen MT, Johnsen SP, Tjø nneland A, Overvad K, Dethlefsen C, Kristensen SR. Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow-up study. Eur J Intern Med. 2010;21:26 8-272.
18. Huerta C, Johansson S, Wallander MA, García Rodrí guez LA. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med. 2007;167:935-943.
19. Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thrombosis: a population-based study. J Throm b Haemost. 2007;5:692-699.
20. Guijarro R, San Roman CM, Perello JI, Nuno E; Efficiency Group of the Internal Medicine Services of Andalusia; Strategic Plan of SADEMI (Andalusia Society of Internal Me dicine). A study of hospital discharges for venous thromboembolism in the south of Spain. An analysis of 19,170 cases from a regional database from 1998 to 2001. Eur J Intern Med 2005;16:279-286.
21. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost. 2000;83:657-660.
22. Nordström M, Lin dblad B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med. 1992;232:155-160.
23. Kierkegaard A. Incidence of acute deep vein thrombosis in two districts. A phlebographic study. Acta Chir Scand. 1980;146:267-269.
24. Tagalakis V, Patenaude V, Kahn SR, Suissa S. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am J Med. 2013;126:832.e13-832.e21.
25. Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med. 2011;171:831-837.
26. Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P, Folsom AR. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med. 2004;117:19-25.
27. Stein PD, Kayali F, Olson RE, Milford CE. Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census. Am J Med. 2004;116:435-442.
28. Janke RM, McGovern PG, Folsom AR. Mortality, hospital discharges, and case fatality for pulmonary embolism in the Twin Cities: 1980- 1995. J Clin Epidemiol 2000;53:103-109.
29. Klatsky AL, A rmstrong MA, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol. 2000;85:1334-1337.
30. Silverstein MD,Heit JA,Mohr DN,Petterson TM,O'Fallon WM,Melton L.J. 3rd, Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study, Arch Intern Med. 1998;158:585-593.
31. White RH, Zhou H, Romano PS. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med. 1998;128:737-740.
32. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;151:933-938.
33. Shiraev TP, Omari A, Rushworth RL. Trends in pulmonary embolism morbidity and mortality in Australia. Thromb Res. 2013;132:19-25.
34. Ho WK, Hankey GJ, Eikelboom JW. The incidence of venous thromboembolism: a prospective, community-based study in Perth, Western Australia. Med J Aust. 2008;189:144-147.
35. Vá zquez FJ, Posadas-Martínez ML, Vicens J, González Bernaldo de Quiró s F, Giunta DH. Incidence rate of symptomatic venous thromboembolic disease in patients from a medical care program in Buenos Aires, Argentina: a prospective cohort. Thromb J. 2013;11:16.
36. Jang MJ, Bang SM, Oh D. Incidence of venous thromboembolism in Korea: from the Health Insurance Review and Assessment Service database. J Thromb Haemost 2011;9:85-91.
37. Lee CH, Lin LJ, Cheng CL, Kao Yang YH, Chen JY, Tsai LM. Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese population. J Thromb Haemost. 2010;8:1515-1523.
38. Cheuk BL, Cheung GC, Cheng SW. Epidemiology of venous thromboembolism in a Chinese population. Br J Surg. 2004;91:424-428.
39. Woo KS, Tse LK, Tse CY, Metreweli C, Vallance-Owen J. The prevalence and pattern of pulmonary thromboembolism in the Chinese in Hong Kong. Int J Cardiol. 1988;20:373-380.
40. Krö ger K, Moerchel Ch, Moysidis T, Santosa F. Incidence rate of pulmonary embolism in Germany: data from the federal statistical office. J Thromb Thrombolysis. 2010;29:349-353.
41. Deitelzweig SB, Johnson BH, Lin J, Schulman KL. Prevalence of clinical venous t hromboembolism in the USA: current trends and future projections. Am J Hematol. 2011;86:217-220.
42. Deitelzweig SB, Lin J, Johnson BH, Schulman KL. Venous thromboembolism in the US: does race matter?J Thromb Thrombolysis. 2011;31:133-138.
43. Abdul Sultan A, Tata LJ, Grainge MJ, West J. The incidence of first venous thromboembolism in and around pregnancy using linked primary and sec ondary care data: a population based cohort study from England and comparative meta-analysis. PLoS One. 2013;8:e70310.
44. Kane EV, Calderwood C, Dobbie R, Morris C, Roman E, Greer IA. A population-based study of venous thrombosis in pregnancy in Scotland 1980 -2005. Eur J Obstet Gynecol Reprod Bio 2013;169:223-229.
45. Heyl PS, Sappenfield WM, Burch D, Hernandez LE, Kavanaugh VM, Hill WC. Pregnancy-related deaths due to pulmonary embolism: findings from two state-based mortality reviews. Matern Child Health J. 2013;17:1230-1235.
46. Virkus RA, Lokkegaard EC, Bergholt T, Mogensen U, Langhoff-Roos J, Lidegaard O. Venous thromboembolism in pregnant and puerperal women in Denmark 1995- 2005. A national cohort study. Thromb Haemost 2011;106:304-309.
47. Berg CJ, Callaghan WM, Syverson C, Henderson Z. Pregnancyrelated mortality in the United States, 1998 to 2005. Obstet Gynecol 2010;116:1302-1309.
48. Sharma S, Monga D. Venous thromboembolism during pregnancy and the post-partum period: incidence and risk factors in a large Victorian health service. Aust N Z J Obstet Gynaecol. 2008;48:44-49.
49. Samuelsson E, Hellgren M, Högberg U. Pregnancy-related deaths due to pulmonary embolism in Sweden. Acta Obstet Gynecol Scand. 2007;86:435-443.
50. Wen SW, H uang L, Liston R, Heaman M, Baskett T, Rusen ID, Joseph KS, Kramer MS; Maternal Health Study Group, Canadian Perinatal Surveillance System. Severe maternal morbidity in Canada, 1991 -2001. CMAJ 2005;173:759-764.
51. Fawcus SR, van Coeverden de Groot HA, Isaacs S. A 50-year audit of maternal mortality in the Peninsula Maternal and Neonatal Service, Cape Town (1953- 2002). BJOG 2005;112:1257-1263.
52. Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ 3rd. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143:697-706.
53. Sullivan EA, Ford JB, Chambers G, Slaytor EK. Maternal mortality in Australia, 1973- 1996. Aust N Z J Obstet Gynaecol 2004;44:452-457; discussion 377.
54. Lindqvist P, Dahlbä ck B, Mar?ál K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol. 1999;94:595-599.
55. Santosa F, Moysidis T, Moerchel C, Kroger K, Bufe A. Pulmonary embolism in young people. Trends in Germany from 2005 to 2011. Hamostaseologie 2014;34:88-92.
56. Reardon G, Pandya N, Nutescu EA, Lamori J, Damaraju CV, Schein J, Bookhart B. Incidence of venous thromboembolism in nursing home residents. J Am Med Dir Assoc. 2013;14:578-584.
57. Schmidt M, Johannesdottir SA, Lemeshow S, Lash TL, Ulrichsen SP, Bøtker HE, Sø rensen HT. Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: a Danish 33-year follow-up study. BMJ Open. 2013;3:.
58. . Sweetland S, Beral V, Balkwill A, Liu B, Benson VS, Canonico M, Green J, Reeves GK; Million Women Study Collaborators. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone thera py in a large prospective study. J Thromb Haemost. 2012;10:2277-2286.
59. Moysidis T, Krö ger K, Moerchel C, Santosa F, Gröchenig E. Pulmonary embolism in young males and females in Germany: d ata from the Federal Statistical Office. Blood Coagul Fibrinolysis. 2010;21:511-515.
60. Lutsey PL, Virnig BA, Durham SB, Steffen LM, Hirsch AT, Jacobs DR Jr, Folsom AR. Correlates a nd consequences of venous thromboembolism: The Iowa Women's Health Study. Am J Public Health. 2010;100:1506-1513.
61. Spannagl M, Heinemann LA, Dominh T, Assmann A, Schramm W, Schürmann R. Comparison o f incidence/risk of venous thromboembolism (VTE) among selected clinical and hereditary risk markers: a communitybased cohort study. Thromb J. 2005;3:8.
62. Samuelsson E, Hä gg S. Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users. Acta Obstet Gynecol Scand. 2004;83:674-681.
63. Mellemkjaer L, Sø rensen HT, Dreyer L, Olsen J, Olsen JH. Admission for and mortality from primary venous thromboembolism in women of fertile age in Denmark, 1977 -95. BMJ. 1999;319:820-821.
64. Kniffin WD Jr, Baron JA, Barrett J, Bi rkmeyer JD, Anderson FA Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med. 1994;154:861-866.
65. Gaborit FS, Overvad K, N ørgaard M, Kristensen SR, Tjø nneland A, Severinsen MT. Alcohol intake and risk of venous thromboembolism. A Danish follow-up study. Thromb Haemost. 2013;110:39-45.
66. Kunisawa S, Ikai H, Iman aka Y. Incidence and prevention of postoperative venous thromboembolism: are they meaningful quality indicators in Japanese health care settings?World J Surg. 2012;36:280-286.
67. White RH, Dager WE, Zhou H, Murin S. Racial and gender differences in the incidence of recurrent venous thromboembolism. Thromb Haemost. 2006;96:267-273.
68. Beemath A, Skaf E, Stein PD. Pulmonary embolism as a cause of death in adults who died with heart failure. Am J Cardiol. 2006;98:1073-1075.
69. Petrauskiene V, Falk M, Waernbaum I, Norberg M, Eriksson JW. The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia. 2005;48:1017-1021.
70. Gomes JP, Shaheen WH, Truong SV, Brown EF, Beasley BW, Gajewski BJ. Incidence of venous thromboembolic events among nursing home residents. J Gen Intern Med. 2003;18:934-936.
71. Stein PD, Matta F, Yaekoub AY. Incidence of vena cava thrombosis in the United States. Am J Cardiol. 2008;102:927-929.
72. Jha AK, Larizgoitia I, Audera-Lopez C, Prasopa-Plaizier N, Waters H, Bates DW. The global burden of unsafe medical care: analytic modelling of observational studies. BMJ Qual Saf. 2013;22:809-815.
73. Access Economics Pty Limited. The Burden of Venous Thromboembolism in Australia. The Australia and New Zealand Working Party on the Management and Prevention of Venous Thromboembolism. Sydney: He alth Education and Management. 2008.
74. Wilson RM, Michel P, Olsen S, et al; WHO Patient Safety EMRO/AFRO Working Group. Patient safety in developing countries: retrospective estimation of scale and nature of ha rm to patients in hospital. BMJ. 2012;344:e832.
75. Aranaz-André s JM, Aibar-Remón C, Limón-Ramírez R, Amarilla A, Restrepo FR, Urroz O, Sarabia O, García-Corcuera LV, Terol-García E, Agra-Varela Y, Gonseth-García J, Bates DW, Larizgoitia I; IBEAS Team. Prevalence of adverse events in the hospitals of five Latin American countries: results of the ?Iberoamerican Study of Adverse Events' (IBEAS). BMJ Qual Saf. 2011;20:1043-1051.
76. Engbers MJ, van Hylckama Vlieg A, Rosendaal FR. Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost. 2010;8:2105-2112.
77. Angchaisuksiri P. Venous thromboembolism in Asia-an unrecognised and under-treated problem?Thromb Haemost. 2011;106:585-590.
78. Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol. 2008;28:370-372.
79. Heit J, Cohen AT, Anderson FJ. Estimated annual number of incident and recurrent, fatal and non-fatal venous thromboembolism (VTE) events in the US. Blood 2005;106:267A.
80. Kahn SR, Hirsch A, Shrier I. Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med. 2002;162:1144-1148.
81. Kachroo S, Boyd D, Bookhart BK, LaMori J, Schein JR, Rosenberg DJ, Reynolds MW. Quality of life and economic costs associated with postthrombotic syndrome. Am J Health Syst Pharm. 2012;69:567-572.
82. Heit JA, Ro oke TW, Silverstein MD, Mohr DN, Lohse CM, Petterson TM, O'Fallon WM, Melton LJ 3rd. Trends in the incidence of venous stasis syndrome and venous ulcer: a 25-year population-based study. J Vasc Surg. 2001;33:1022-1027.
83. Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P; Thromboembolic Pulmonary Hypertension Study G roup. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350:2257-2264.
84. Noble S, Lewis R, Whithers J, Lewis S, Bennett P. Long-term ps ychological consequences of symptomatic pulmonary embolism: a qualitative study. BMJ Open. 2014;4:e004561.
85. Cohen AT, Spiro TE, Buller H, HR, Haskell L, Hu D, Hull R, Mebazaa A, Me rli G, Schellong S, Spyropoulos AC, Tapson V; MAGELLAN Investigators. Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med 2013;368:513-523.
86. Goldhaber SZ, Leiz orovicz A, Kakkar AK, Haas SK, Merli G, Knabb RM, Weitz JI; ADOPT Trial Investigators. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med. 2011;365:2167-2177.
87. Raskob GE, Gallus AS, Pineo GF, Chen D, Ramirez LM, Wright RT, Lassen MR. Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials. J Bone Joint Surg Br. 2012;94:257-264.
88. Wells PS, Forgie MA, Rodger MA. Treatment of venous thromboembolism. JAMA 2014;311:717-728.
89. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Zayaruzny M, Emery L, Anderson FA Jr; ENDORSE Investigators. Venous thromboem bolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371:387- 394.
90. Erratum in: Lancet. 2008;371:1914.
91. Lester W, Free mantle N, Begaj I, Ray D, Wood J, Pagano D. Fatal venous thromboembolism associated with hospital admission: a cohort study to assess the impact of a national risk assessment target. Heart. 2013;99:1734-1739.
92. Catterick D, Hunt BJ. Impact of the national venous thromboembolism risk assessment tool in secondary care in England: retrospective population-based database study. Blood Coagul Fibrinolysis. 2014;25:5 71-576.
93. Sixty-Sixth World Health Assembly. Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases. May 27, 2013. http://apps.who.i nt/gb/ebwha/pdf-files/WHA66/A66-R10-en.pdf. Accessed August 14, 2014.